<DOC>
	<DOCNO>NCT00679848</DOCNO>
	<brief_summary>The purpose study evaluate safety , technical feasibility , initial effectiveness ( i.e. , weight loss primarily measure percent excess weight loss ) TGVR perform use Bard RESTORe Suturing System</brief_summary>
	<brief_title>Transoral Gastric Volume Reduction Intervention Weight Management</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<criteria>Male , Female ; age &gt; 18yrs Â£ 60 yr BMI 3045 kg/m2 History obesity 5 yr ; attempt weight control ineffective Weight stable Willing comply study requirement Agrees additional weight loss surgery , reconstructive surgery liposuction one year follow procedure Sign inform consent form Women childbearing age practice effective birth control method pregnant lactate Mallampati score = 4 Uncontrolled hypothyroidism Previous interventional/surgical treatment obesity ; prior gastric surgery History diabetes &gt; 10 yr difficult control diabetes Presence hiatal hernia Congenital acquire anomaly GI tract Severe cardiovascular , cerebrovascular , cardiopulmonary disease Chronic acute upper gastrointestinal bleeding condition Helicobacter pylori positive Immunocompromised Subjects eat disorder Acute chronic infection Significant movement limitation Not candidate conscious general anesthesia Active substance abuse Life expectancy &lt; 2 year Enrolled another investigational drug device trial complete primary endpoint clinically interfere study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Weight Loss</keyword>
	<keyword>Transoral Suturing</keyword>
	<keyword>Experimental</keyword>
</DOC>